Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00111020
Recruitment Status : Completed
First Posted : May 17, 2005
Last Update Posted : August 6, 2014
Information provided by (Responsible Party):